CYTOKINE STATUS OF PREMATURE NEWBORNS WITH DISORDERED INTESTINAL MICROBIOME
Scientific and Innovative Therapy · 2025
DOI: 10.64582/ivit.uz.254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Shakhnoza Mukhamedova und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The study of cytokine status in preterm infants with intestinal microbiota disorders showed an increase in IL-1β levels in the main groups compared to healthy newborns. IL-10 was also elevated 1.4 times compared to control values. This condition is explained by preterm birth, functional immaturity of the immune system, and hyperactivation of protective and adaptive mechanisms in preterm infants; however, it simultaneously serves as a diagnostic marker of systemic inflammatory response. Newborns with high concentrations of IL-1β were classified into the high-risk sepsis group and received additional antibacterial therapy.
Zitieren
APA
Mukhamedova, S., & Abdieva, N. (2025). CYTOKINE STATUS OF PREMATURE NEWBORNS WITH DISORDERED INTESTINAL MICROBIOME. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.254
Vancouver
Mukhamedova S, Abdieva N. CYTOKINE STATUS OF PREMATURE NEWBORNS WITH DISORDERED INTESTINAL MICROBIOME. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.254
BibTeX
@article{Mukhamedova2025,
author = {Mukhamedova, Shakhnoza and Abdieva, Nargiza},
title = {CYTOKINE STATUS OF PREMATURE NEWBORNS WITH DISORDERED INTESTINAL MICROBIOME},
journal = {Scientific and Innovative Therapy},
year = {2025},
doi = {10.64582/ivit.uz.254}
}
EUVIMED